Última revisão: 25 GUA 2021
Última atualização: 14 Mai 2021

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • preocupação excessiva que dura há, pelo menos, 6 meses
  • ansiedade não limitada a outro transtorno mental
  • ansiedade não decorrente de medicamento ou substância
  • tensão muscular
  • perturbação do sono
  • fadiga
  • sono agitado
  • irritabilidade
  • baixa concentração

Outros fatores diagnósticos

  • cefaleia
  • sudorese
  • tontura
  • sintomas gastrointestinais
  • dores musculares
  • frequência cardíaca aumentada
  • dispneia
  • tremores
  • resposta de sobressalto exagerada
  • dor torácica

Fatores de risco

  • história familiar de ansiedade
  • estresse emocional ou físico
  • história de trauma emocional, físico ou sexual
  • outro transtorno de ansiedade
  • doença física crônica
  • sexo feminino

Investigações diagnósticas

Investigações a serem consideradas

  • testes da função tireoidiana
  • exame de urina para detecção de drogas
  • exame de urina de 24 horas para ácido vanilmandélico e metanefrinas
  • testes de função pulmonar
  • eletrocardiograma (ECG)

Algoritmo de tratamento

Colaboradores

Autores

Christopher Gale, BHB, MPH, MBChB, FRANZCP

Research Director

Consultant Psychiatrist

Southern District Health Board

Senior Lecturer

Department of Psychological Medicine

Dunedin School of Medicine

Otago University

Dunedin

New Zealand

Declarações

CG is an author of the Royal Australian and New Zealand College of Psychiatrists clinical practice guideline on social phobia, panic disorder, and generalised anxiety disorder. He is a contributor to the Cochrane Common Mental Disorders group, writing on generalised anxiety disorder, and has authored papers relating to heterogeneity of the database separately to Cochrane work. Otago University has commercial and research relationships with multiple pharmaceutical companies. He is an author of a number of references cited in this topic.

Agradecimentos

Dr Christopher Gale would like to gratefully acknowledge Dr Richard P. Swinson, Dr Elizabeth Hoge, and Dr Phebe Tucker, previous contributors to this topic.

Declarações

RPS has personally received royalties for articles published in UpToDate (Wolters Kluwer) and the Compendium of Therapeutic Choices, 2nd edition (Canadian Pharmacists Association). EH is an author of a number of references cited in this topic. PT has done research for GlaxoSmithKline, Bristol-Myers Squibb, Wyeth Pharmaceuticals, Astra-Zeneca, Cephalon, Inc., and Ortho-McNeil. She has also consulted for Forest Pharmaceuticals and received honoraria from Pfizer, Inc. and Forest Pharmaceuticals.

Revisores

Lori Davis, MD

Research Director

University of Alabama

School of Medicine Tuscaloosa Campus

College of Community Health Sciences

Tuscaloosa

AL

Declarações

LD declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal